Home » Topics » Regulatory

Regulatory
RSS

FDA approves axitinib for advanced renal cell carcinoma

Jan. 30, 2012

Indication for Gadovist 1.0 is expanded

Jan. 30, 2012

FDA expands Keppra indication

Jan. 26, 2012

FDA approves gel for actinic keratosis

Jan. 26, 2012

Extended indication for Rebif approved in E.U.

Jan. 25, 2012

FDA approves subcutaneous Velcade

Jan. 24, 2012

FDA approves new pediatric formulations of Viread

Jan. 19, 2012

Abilify approved for new indication in Japan

Jan. 18, 2012

FDA approves new product for methotrexate poisoning due to impaired renal function

Jan. 18, 2012

World's first hepatitis E vaccine approved in China

Jan. 16, 2012